The US Department of Agriculture is expected to announce today that it's scaling back inspections of American cattle for signs of mad cow disease. Some cattlemen think that's a mistake, Helen Palmer reports.
Democrats today are highlighting Medicare's "Doughnut Hole" coverage gap, but there's disagreement over just how many people will actually fall into the hole. Helen Palmer reports.
The Senate is debating a bill that would allow federal funding of stem cell research. It's expected to pass, but President Bush has threatened to veto any such bill — and money may not be the key issue, Hillary Wicai explains.
The Senate today begins debate on a bill that could open the door for more federal funding of stem cell research. But President Bush has vowed to stamp his first-ever veto on the legislation. Sarah Gardner reports.
There's a new trend in health care delivery: Your neighborhood drug store could soon offer in-store clinics that might save you a trip to the doctor's office. Lisa Napoli reports.
With yesterday's verdict in New Jersey, Merck has now won more than half of the Vioxx liability lawsuits filed against it. Is the decision to fight individual cases paying off? Helen Palmer reports.
The supplement widely used to relieve joint pain has been found to effectively fade age spots as well. Helen Palmer reports on glucosamine's new market potential.
The Senate has drafted a resolution making it easier for Americans to buy cheaper prescription drugs north of the border. But as Helen Palmer reports, those drugs aren't as attractive as they once were.
Government auditors find insurance companies give incorrect information about the new Medicare drug benefit program two-thirds of the time. Hillary Wicai reports.
